From: healthline.com Breast cancer is the most common type of cancer in females. The American Cancer Society estimates that 310,720 femalesTrusted Source in the United States will receive a breast cancer diagnosis in 2024. Breast cancer has different subtypes based on markers found on the cancer cells: Hormone receptors (HRs) include those for estrogen (ER) and progesterone (PR). These two …
Integrative Approaches in Triple-Negative Breast Cancer
By: Amanda Brink, DNP, APRN, FNP-BC, AOCNP From: cancernursingtoday.com Triple-negative breast cancer (TNBC) remains a highly aggressive subtype with limited targeted treatment options. Oncology nurses care for patients who often face significant physical, emotional, and psychosocial challenges, including treatment-related side effects and psychological distress. In addition to pharmacologic management of these symptoms, nurses and patients frequently turn to integrative approaches …
Tailoring Treatment: Real-World Evidence Guides ADC Sequencing in Breast Cancer
By: Sabrina Serani From: argetedonc.com Key Takeaways Real-world data analysis reveals optimal ADC sequencing for HER2-negative breast cancer, aiding personalized treatment decisions. T-DXd shows superior efficacy in hormone receptor-positive tumors, while sacituzumab govitecan benefits HR-negative, HER2-null patients. The study highlights the critical role of real-world evidence in guiding treatment choices without head-to-head clinical trials. Precision medicine is emphasized, particularly for …
This Common Anti-Nausea Pill Could Be a Game-Changer for Hard-To-Treat Breast Cancers
By: Monash University From: scitechdaily.com An anti-nausea drug may reduce recurrence and death in aggressive breast cancer. Scientists are exploring its broader use in oncology. A recent study has identified a link between a widely used anti-nausea drug and improved outcomes for women with early-stage breast cancer, with especially notable effects in those with triple negative breast cancer. Researchers from …
Breast Cancer Treatment Options
From: healthline.com There are many different types of breast cancer. Some treatments target specific characteristics of cancer cells, so they only work on those particular cancers. Some treatments depend on how fast the cancer is growing and how far it has spread. Breast cancer treatment isn’t the same for everyone. Read on to learn more about breast cancer treatments and …
Vitamin D Supplements May Boost Breast Cancer Treatment Success
By: Alyssa Sybertz From: .healthcentral.com Vitamin D has been credited with a variety of important health benefits, from strengthening bones and boosting immunity to potentially counteracting the development of depression and heart disease. Now, a new Brazilian study published in the journal Nutrition and Cancer suggests that supplementing with relatively low doses of vitamin D may improve response to chemotherapy …
KAT6 Inhibition Shows Path to Overcoming Resistance Mechanisms in ER+ Breast Cancer
By: Kyle Doherty From: .onclive.com Due to its amplification in approximately 12% to 15% of patients with estrogen receptor (ER)–positive breast cancer and ability to repress ER gene transcription, thereby overcoming ESR1-mediated resistance to endocrine therapy, KAT6 had garnered attention as a therapeutic target of interest in the space.1 “KAT6 is a histone [lysine] acetyltransferase complex,” Sarah Naomi Olsen, PhD, …
Revolutionizing Triple-Negative Breast Cancer Treatment: A Safer Path Forward
By: Sabrina Serani From: targetedonc.com Triple-negative breast cancer (TNBC) is a notoriously aggressive form of cancer, often requiring intense and highly toxic treatment regimens. The current standard of care frequently involves anthracyclines, a class of chemotherapy drugs known for their severe adverse effects, including secondary blood cancers like leukemia and irreversible heart failure. This urgent unmet need for effective yet …
Breast cancer test predicts relapse risk in just two weeks – and could spare thousands of patients from unnecessary treatment
From: icr.ac.uk Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple test which can identify whether or not their cancer is likely to return – just two weeks after starting treatment. The test – which is already approved for clinical use – could have a transformative impact on the treatment of oestrogen receptor positive, …
Personalized Medicine Advances with New Tool to Guide Breast Cancer Treatment Choices
Source: Yale School of Medicine From: yale.edu Yale pathology researchers created a dependable test that precisely measures key proteins found in breast cancer cells that can help oncologists choose the most effective targeted therapies for patients, says a report published July 16 in Precision Oncology, a journal of the American Society of Clinical Oncology. The assay, named Troplex™, was designed …